elder law weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of elder law weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Guidant Corporation
E.U. approves two heart disease treatments
June 23rd, 2004
Guidant Corporation (NYSE:GDT) announced the Conformite Europeenne (CE) Mark approval of a new coronary stent system and a coronary dilatation catheter. The stent system, called Multi-link Mini Vision, is Guidan'ts first cobalt chromium stent designed for treating coronary artery disease in small vessels. The catheter is called the Voyager Coronary Dilatation Catheter. "These two approvals continue Guidant's leadership in developing innovative technology for interventional cardiology," said Dana G. Mead, Jr., Guidant's president of vascular intervention. "Both the Multi-link Mini Vision Coronary Stent System and the Voyager Coronary Dilatation...
Source: elder law weekly (2004-06-23)
|
